Loading data
TYRANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 102.93 m USD | 80.08 m USD | 62.52 m USD | 43.01 m USD | 20.64 m USD |
| Operating profit | -132.76 m USD | -104.18 m USD | -79.95 m USD | -58.93 m USD | -26.29 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 2 k USD | 1 k USD |
| Net income (reported basis) | -119.95 m USD | -86.48 m USD | -69.13 m USD | -55.33 m USD | -26.29 m USD |
| Basic earnings per share | -2.01 USD/share | -1.51 USD/share | -1.62 USD/share | -1.32 USD/share | -1.91 USD/share |
| Diluted earnings per share | -2.01 USD/share | -1.51 USD/share | -1.62 USD/share | -1.32 USD/share | -1.91 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.